Drug General Information
Drug ID	D0D5QT
Former ID	DNC012095
Drug Name	1-(3-Bromomethyl-phenyl)-2,2,2-trifluoro-ethanone
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[526149]
Structure		Download 2D MOL 3D MOL
Formula	C9H6BrF3O
Canonical SMILES	C1=CC(=CC(=C1)CBr)C(=O)C(F)(F)F
InChI	1S/C9H6BrF3O/c10-5-6-2-1-3-7(4-6)8(14)9(11,12)13/h1-4H,5H2
InChIKey	PJBFZGACRBKRKV-UHFFFAOYSA-N
PubChem Compound ID	10858440
Target and Pathway
Target(s)	Acetylcholinesterase	Target Info	Inhibitor	[526149]
KEGG Pathway	Glycerophospholipid metabolism
	Cholinergic synapse
PANTHER Pathway	Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Muscarinic acetylcholine receptor 2 and 4 signaling pathway
	Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database	ATF-2 transcription factor network
PathWhiz Pathway	Phospholipid Biosynthesis
WikiPathways	Monoamine Transport
	Biogenic Amine Synthesis
	Acetylcholine Synthesis
	Integrated Pancreatic Cancer Pathway
References
Ref 526149	J Med Chem. 2001 Sep 27;44(20):3203-15.A structure-based design approach to the development of novel, reversible AChE inhibitors.
Ref 526149	J Med Chem. 2001 Sep 27;44(20):3203-15.A structure-based design approach to the development of novel, reversible AChE inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.